Cargando…

Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)

BACKGROUND: Patients with advanced biliary tract cancer who progress on first-line therapy have limited treatment options. The TreeTopp study assessed varlitinib, a reversible small molecule pan-human epidermal growth factor receptor inhibitor, plus capecitabine in previously treated advanced biliar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Javle, M.M., Oh, D.-Y., Ikeda, M., Yong, W.-P., Hsu, K., Lindmark, B., McIntyre, N., Firth, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685988/ https://www.ncbi.nlm.nih.gov/pubmed/34922298 http://dx.doi.org/10.1016/j.esmoop.2021.100314

Ejemplares similares

Gold Nanoparticles for Targeting Varlitinib to Human Pancreatic Cancer Cells
por: Coelho, Sílvia Castro, et al.
Publicado: (2018)

Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial
por: Kim, Seung Tae, et al.
Publicado: (2019)

Doxorubicin and Varlitinib Delivery by Functionalized Gold Nanoparticles Against Human Pancreatic Adenocarcinoma
por: Coelho, Sílvia Castro, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers
por: Chen, Ruijia, et al.
Publicado: (2022)

Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells
por: Liu, Chun-Yu, et al.
Publicado: (2019)

In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines
por: Dokduang, Hasaya, et al.
Publicado: (2020)

Immune checkpoint inhibitors plus capecitabine and oxaliplatin in unresectable or advanced biliary tract cancer patients: A retrospective study
por: Zhao, Jie, et al.
Publicado: (2022)

Reliability Analysis of the New Exponential Inverted Topp–Leone Distribution with Applications
por: Metwally, Ahmed Sayed M., et al.
Publicado: (2021)

The Burr III-Topp-Leone-G family of distributions with applications
por: Chipepa, Fastel, et al.
Publicado: (2021)

The Odd Weibull Inverse Topp–Leone Distribution with Applications to COVID-19 Data
por: Almetwally, Ehab M.
Publicado: (2021)

Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy
por: Yamamoto, Akinaru, et al.
Publicado: (2020)

A New Power Topp–Leone distribution with applications to engineering and industry data
por: Atchadé, Mintodê Nicodème, et al.
Publicado: (2023)

The Topp-Leone Generalized Inverted Exponential Distribution with Real Data Applications
por: Al-Saiary, Zakeia A., et al.
Publicado: (2020)

A New Power Topp–Leone Generated Family of Distributions with Applications
por: Bantan, Rashad A. R., et al.
Publicado: (2019)

The statistical properties and applications of the alpha power Topp-Leone-G distribution
por: Eghwerido, Joseph Thomas, et al.
Publicado: (2022)

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
por: Lee, Matilda Xinwei, et al.
Publicado: (2022)

Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer
por: Wist, E. A., et al.
Publicado: (2012)

ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
por: Chen, Jing, et al.
Publicado: (2009)

A New Extension of the Topp–Leone-Family of Models with Applications to Real Data
por: Muhammad, Mustapha, et al.
Publicado: (2022)

Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial
por: Nehls, O, et al.
Publicado: (2008)

Editorial Comment to Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy
por: Kandori, Shuya
Publicado: (2020)

Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer
por: Ren, Lanqi, et al.
Publicado: (2023)

Celebrating discovery across the tree of life
por: McIntyre, Lauren M
Publicado: (2023)

Pulse EPR Measurements of Intramolecular Distances in a TOPP-Labeled Transmembrane Peptide in Lipids
por: Halbmair, Karin, et al.
Publicado: (2016)

Leslie Topp, Freedom and the Cage: Modern Architecture and Psychiatry in Central Europe, 1890–1914
por: Marks, Sarah
Publicado: (2019)

Studies of transmembrane peptides by pulse dipolar spectroscopy with semi-rigid TOPP spin labels
por: Tkach, Igor, et al.
Publicado: (2021)

Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy
por: Grisanti, Salvatore, et al.
Publicado: (2021)

A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract
por: Graham, J. S., et al.
Publicado: (2016)

Retrospective study of preoperative chemoradiotherapy with capecitabine versus capecitabine plus oxaliplatin for locally advanced rectal cancer
por: Yang, Xiao-Hui, et al.
Publicado: (2020)

Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer
por: Lee, Jieun, et al.
Publicado: (2015)

Arabidopsis DELLA Protein Degradation Is Controlled by a Type-One Protein Phosphatase, TOPP4
por: Qin, Qianqian, et al.
Publicado: (2014)

Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction
por: Baird, R, et al.
Publicado: (2011)

Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer
por: Peng, Jingyuan, et al.
Publicado: (2018)

Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study
por: Javle, M, et al.
Publicado: (2009)

Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
por: Rhee, Jiyoung, et al.
Publicado: (2019)

A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer
por: Bozkaya, Yakup, et al.
Publicado: (2018)

ToppMiR: ranking microRNAs and their mRNA targets based on biological functions and context
por: Wu, Chao, et al.
Publicado: (2014)

Type II exponentiated half-logistic Topp-Leone Marshall-Olkin-G family of distributions with applications
por: Moakofi, Thatayaone, et al.
Publicado: (2021)

A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial
por: Chen, Ming-Huang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c5dakqdm5jt8093v01nle24fg7